INTRODUCTION
There has been an explosive increase in the prevalence of type 2 diabetes T2D 1 . In light of the rapid increase in the number of elderly people around the world, T2D has become a medical and socioeconomic issue in industrialized countries. Accumulating evidence indicates that lifestyle interventions including dietary modification and exercise are associated with improved glycemic control in patients with T2D. Since eating is a major aspect of daily life, diets may have a strong influence on the development of diabetes and its subsequent progression. It has been suggested that the quality of dietary lipids may be an important modulator of the risks associated with lifestyle-related disease. Compared with long-chain fatty acids LCFAs , medium-chain fatty acids MCFAs; composed of chains of 8 -12 carbon atoms have several unique and physiologic properties. Medium-chain triacylglycerols MCTs , composed exclusively of MCFAs, are hy-drolyzed rapidly. The resulting MCFAs are absorbed directly by the liver via the portal vein. In the liver, the MCFAs are more easily oxidized since its intramitochondrial transport does not require a carnitine transport system, which is a rate-limiting step of mitochondrial β-oxidation 2, 3 . These characteristics make MCTs a useful dietary treatment for preventing and reversing obesity 3 . Previous studies have also reported that treatment with MCTs can improve insulin sensitivity and glucose tolerance in T2D subjects 4, 5 .
Although MCTs may be a valuable tool for preventing and reversing obesity and T2D, it is not feasible to substitute MCTs for long-chain triacylglycerol LCTs in the diet for long-term therapy because the lower smoking point of MCTs and greater tendency to bubble limit the use of MCTs as cooking oil. A cooking oil containing medium-and long-chain fatty acids in the same glycerol molecule MLCT prepared by random interesterification has been used widely in Japan.
MLCT has overcome the disadvantages encountered with MCT and can easily replace LCT in the daily diet. We previously reported that the dietary intake of MLCT induced a significant decrease in the mesenteric fat mass in rats fed a high-fat diet and ameliorated their whole-body insulin resistance, which precedes the onset of T2D, suggesting that MLCT can prevent the future development of T2D 6 .
However, it remains unclear whether MLCT is also effective for preventing and reversing the progression of hyperglycemia in patients who have already developed T2D. The purpose of the present study was thus to examine the effects of the dietary intake of MLCT on hyperglycemia in diabetic ob/ob mice, which is one of the most commonly used animal models of T2D.
EXPERIMENTAL

Materials
The MLCT and LCT rapeseed oil oils were obtained from The Nisshin OilliO Group Ltd. Tokyo . Their fatty acid compositions, as measured by gas chromatography 7 , are listed in Table 1 .
Treatment of animals
Five-week-old male ob/ob mice were obtained from Japan SLC Hamamatsu, Shizuoka, Japan and were individually housed in cages. The temperature of the animal room was set at 23 1 with humidity of 50 5 and illumination from 09:00 to 21:00 h. All animals were treated in accordance with the guidelines for the care and use of laboratory animals Notification of the Prime Minister s Office in Japan . The experimental plan was approved by the Laboratory Animal Care Committee of the Research Laboratory, The Nisshin OilliO Group, Ltd. During the acclimation period, the mice were allowed free access to water and a diet based on the AIN-93G formula.
The ob/ob mice were separated into two groups matched for body weight, plasma glucose and insulin concentrations after a 1-wk acclimation. Each group of mice was allowed free access to the experimental diet containing LCT n 5 or MLCT n 5 for 3 wks. The composition of the diet is presented in Table 2 . Both diets were based on the AIN-93G formula with the modification that each oil was increased from 70 g to 100 g/kg of the diet. Each group s food intake and body weights were recorded every second day.
Blood sampling
To determine the effects of LCT intake and those of MLCT intake on plasma glucose and insulin levels in the freely fed state, we sampled the blood of each mouse between 09:00 and 09:30 in the morning immediately after the 12-h dark period once a week during the 3 wks of dietary treatment. The blood samples were collected into capillary tubes from the tail vein. The capillary tubes were then centrifuged and plasma samples were stored at 80 until the analysis.
Tissue collection
At the end of the dietary treatment day 21 , the mice were killed by bleeding under anesthesia with isoflurane. The mice were not deprived of food before sacrificing. Liver and intra-abdominal fats epididymal, mesenteric, and retroperitoneal fat pads were removed and weighed. Liver samples were frozen in liquid N 2 and stored at 80 until the analysis.
Analytical procedure
Plasma glucose was determined using Glucose C2 Test 
Statistical analysis
The data are presented as mean SEM. We performed a two-way analysis of variance ANOVA Jandel Sigma Stat, San Jose, CA to examine the effects of time and dietary conditions on plasma glucose and insulin concentrations in the fed state. We performed least-square regression analyses to examine relationships between variables. For the other experiments, the statistical analysis was performed using Student s t-test Jandel Sigma Stat . Statistical significance was defined as p 0.05.
RESULTS
3.1 Body weight, food intake, intra-abdominal fat, and liver weights There were no significant differences in the final body weights and body weight gains between the LCT and MLCT groups Table 3 . Food intake and food efficiency were not significantly different between the two groups Table 3 . The total intra-abdominal fat weight in the MLCT group was significantly higher than that observed in the LCT group p 0.05, Table 3 . No significant difference in the liver weight was observed between the LCT and MLCT groups Table 3 .
Liver triacylglycerol and glycogen concentrations
There were no significant differences in liver triacylglycerol or glycogen concentrations between the LCT and MLCT groups 292 32 vs. 322 20 mg/g wet tissue, 134 24 vs. 113 14 μmol/g wet tissue, triacylglycerol and glycogen, respectively . Figure 1 shows the changes in the plasma glucose and insulin levels in the freely fed state during the 3 wks of dietary treatment. Although the plasma glucose concentration in the fed state progressively increased in the LCT group, no such increase in plasma glucose was observed in the MLCT group Fig. 1A . In contrast, the plasma insulin concentration progressively increased during the 3-wk dietary treatment in the MLCT but not in the LCT group Fig. 1B . The two-way ANOVA reveals that dietary treatment had significant effects on the plasma glucose and insulin levels in the fed state, resulting in significantly lower plasma glucose and higher plasma insulin concentrations in the MLCT group compared to the LCT group p 0.01 . No significant interactions between treatment duration wk and dietary conditions on the plasma glucose and insulin were observed.
Plasma glucose and insulin level in the fed state
3.4
Relationship between plasma glucose and plasma insulin concentrations or total intra-abdominal fat mass There was a significant negative correlation between plasma insulin and glucose concentrations in the fed state at the end of dietary treatment day 21 Fig. 2A, r 0 .710, p 0.05 . As shown in Fig. 2B , the total intra-abdominal fat mass tended to be inversely correlated with the plasma glucose concentrations, although the relation did not reach statistical significance r 0.575, p 0.08 .
DISCUSSION
We previously reported that MLCT intake improves excess calorie-induced whole-body insulin resistance, which usually precedes the onset of hyperglycemia, suggesting that MLCT can prevent the development of T2D 6 .
For the purpose of further examining the effects of MLCT on glucose metabolism in individuals who have already de- veloped hyperglycemia, in the present study we evaluated the postprandial glucose levels in diabetic ob/ob mice fed a diet containing MLCT or LCT. We found that the plasma glucose level in the freely fed state gradually increased in the mice fed LCT, but not those fed MLCT Fig. 1A , even though the daily food intake did not differ significantly between the two groups Table 3 . These results suggest that the dietary intake of MLCT prevents or delays the progression of hyperglycemia in T2D. An excessive accumulation of visceral fat is postulated to be a major factor in the development of insulin resistance, which is an early and key defect associated with T2D 12 . It has been well documented that MLCT as well as MCT can induce a significant decrease in the visceral fat mass in both human subjects and experimental animals 13 17 . We previously reported that the feeding of MLCT decreased the mesenteric fat mass in rats fed a high-fat diet, leading to the improvement of whole-body insulin resistance 6 . Based on these findings, our working hypothesis was that the dietary intake of MLCT would induce a decrease in the total intra-abdominal fat mass in diabetic ob/ob mice as well, resulting in improved glucose homeostasis. Contrary to our expectation, the MLCT group mice in the present study had significantly higher total intra-abdominal fat masses than the LCT group Table 3 . In addition, the total intra-abdominal fat mass tended to be negatively associated with the plasma glucose concentration in the fed state Fig. 2B . It is therefore plausible that under the diabetic condition, MLCT intake prevents the progression of hyperglycemia, possibly through the stimulation of glucose uptake in adipose tissue, resulting in an increase rather than a decrease in the total intra-abdominal mass, whereas MLCT may exert its body fat-lowering effects in the healthy or insulin-resistant states without hyperglycemia. However, it remains unclear whether this is a general phenomenon across species. Further studies are necessary to examine the effects of MLCT intake on the intra-abdominal fat masses in diabetic rats or human diabetic patients as well as diabetic ob/ob mice.
As shown in Fig. 1A , the plasma insulin levels in the MLCT group gradually increased during the 3-wk dietary treatment, and a significant inverse correlation was observed between the plasma insulin and glucose concentrations Fig. 2A . These results suggest the possibility that MLCT intake promotes insulin secretion, leading to the stimulation of glucose uptake in adipose tissue and the prevention of hyperglycemia in ob/ob mice. No such insulinotropic effects of MLCT have been reported in healthy humans or animals. It is therefore likely that MLCT exerts the insulinotropic effects only under the hyperglycemic condition.
Candidate mechanisms for the MLCT-induced increase in insulin secretion are incretin hormones such as glucagon-like peptide-1 GLP-1 and glucose-dependent insulinotropic polypeptide GIP . GLP-1 and GIP are hormones that are released from the gut into the bloodstream in response to the ingestion of food. They were shown to potentiate glucose-induced insulin secretion 18 . Especially with respect to GIP, it has been demonstrated that orally administered fat, amino acids and glucose raised the GIP concentration in ob/ob mice, with fat having a particularly strong effect 19 . It is therefore plausible that the MLCT-induced increase in plasma insulin concentration could be attributed to an enhanced GIP secretion from the gut. Although MCT has been shown to have smaller stimulatory effects on GIP secretion compared to LCT 20 , the possibility that the unique structure of MLCT which consists of MCFAs and LCFAs in the same glycerol molecule is effective in the stimulation of GIP release should not be ruled out. Unfortunately, we were unable to determine the plasma GIP levels in this study because the plasma samples were used up to perform the biochemical assays. Future studies are necessary to examine the effects of MLCT intake on GIP and insulin secretion.
CONCLUSION
The dietary intake of MLCT was found to have favorable effects on glycemic control in diabetic ob/ob mice. The mechanism responsible for this phenomenon appears to be, at least in part, the stimulation of glucose uptake in intra-abdominal fat tissue caused by elevated insulin secretion.
